Dr Milton Mozen, director of biochemical research and development at Cutter, said that "Concern about hepatitis transmission" was the reason for experiments with heat treatment in the early 1970s.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Viral Inactivation